ProMIS Neurosciences reported earnings of -$ 0.89 per PMN share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 1.28 |
| Earnings Per Share (Surprise) | -$ 0.89 (+$ 0.39) |
| Last Year's EPS | -$ 5.34 |
| EPS YoY Change |
Out of the last 98 earnings reporting periods, ProMIS Neurosciences beat analysts’ expectations 11 times and fell short of expectations 7 time(s). ProMIS Neurosciences reported earnings per share of -$ 0.89 in the last report surpassing an estimated EPS of -$ 1.28 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 1.28 | -$ 0.89 | -$ 4.11 | |
| Aug 13, 2026 | -$ 1.38 | -$ 1.28 | -$ 4.11 | |
| May 12, 2026 | -$ 1.06 | -$ 1.26 | -$ 6.00 | |
| May 11, 2026 | -$ 1.06 | -$ 1.26 | -$ 7.25 | |
| Mar 30, 2026 | -$ 4.22 | -$ 4.11 | -$ 5.25 | |
| Mar 25, 2026 | -$ 4.66 | -$ 4.11 | -$ 0.50 | |
| Nov 12, 2025 | -$ 3.75 | -$ 6.00 | $ 0.42 | |
| Aug 13, 2025 | -$ 5.50 | -$ 7.25 | -$ 0.13 | |
| May 12, 2025 | -$ 3.00 | -$ 5.25 | -$ 0.19 | |
| Mar 31, 2025 | -$ 3.50 | -$ 0.50 | -$ 0.29 | |
| Nov 14, 2024 | -$ 0.07 | $ 0.42 | -$ 0.09 | |
| Aug 8, 2024 | -$ 0.14 | -$ 0.13 | -$ 0.19 | |
| May 14, 2024 | -$ 0.20 | -$ 0.19 | -$ 0.19 | |
| Apr 3, 2024 | -$ 0.17 | -$ 0.29 | -$ 0.27 | |
| Apr 1, 2024 | -$ 0.17 | -$ 0.09 | -$ 14.50 | |
| Nov 14, 2023 | -$ 0.33 | -$ 0.19 | -$ 22.50 | |
| Nov 13, 2023 | -$ 0.33 | -$ 0.19 | -$ 1.11 | |
| Aug 14, 2023 | - | -$ 0.27 | -$ 9.50 | |
| May 15, 2023 | - | -$ 14.50 | -$ 0.60 | |
| Mar 8, 2023 | - | -$ 22.50 | -$ 9.75 |
ProMIS Neurosciences’s stock was trading at $ 3.76 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, PMN’s price decreased to $ 3.29 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.89 | $ 3.76 | $ 3.29 | |
| Aug 13, 2026 | -$ 1.28 | $ 14.50 | $ 14.86 | |
| May 12, 2026 | -$ 1.26 | $ 10.68 | $ 10.57 | |
| May 11, 2026 | -$ 1.26 | $ 9.83 | $ 10.49 | |
| Mar 30, 2026 | -$ 4.11 | $ 14.74 | $ 12.70 | |
| Mar 25, 2026 | -$ 4.11 | $ 17.43 | $ 15.13 | |
| Nov 12, 2025 | -$ 6.00 | $ 9.88 | $ 9.76 | |
| Aug 13, 2025 | -$ 7.25 | $ 17.50 | $ 15.75 | |
| May 12, 2025 | -$ 5.25 | $ 12.55 | $ 13.00 | |
| Mar 31, 2025 | -$ 0.50 | $ 17.50 | $ 18.87 | |
| Nov 14, 2024 | $ 0.42 | $ 24.50 | $ 24.50 | |
| Aug 8, 2024 | -$ 0.13 | $ 34.75 | $ 30.50 | |
| May 14, 2024 | -$ 0.19 | $ 50.00 | $ 45.00 | |
| Apr 3, 2024 | -$ 0.29 | $ 56.50 | $ 50.25 | |
| Apr 1, 2024 | -$ 0.09 | $ 47.75 | $ 56.50 | |
| Nov 14, 2023 | -$ 0.19 | $ 37.50 | $ 36.00 | |
| Nov 13, 2023 | -$ 0.19 | $ 35.64 | $ 32.92 | |
| Aug 14, 2023 | -$ 0.27 | $ 57.75 | $ 55.00 | |
| May 15, 2023 | -$ 14.50 | $ 151.25 | $ 135.00 | |
| Mar 8, 2023 | -$ 22.50 | $ 120.00 | $ 118.75 |
ProMIS Neurosciences released its most recent earnings reports in November 2026, August 2026, May 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
ProMIS Neurosciences beat analysts’ expectations during the last earnings period by
